Haven't used AmyPore yet?
Ask Trustburn

Ask Trustburn about AmyPore

Based on 11 reviews on Trustburn

Based on reviews on this page. Verify anything important with the company directly.

Questions & Answers

No questions yet β€” be the first to ask.

News & Press

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying widget on your website β€” its a simple way to convert your visitors into customers.

Embed code

<script src="https://trustburn.com/widgets/index.js"></script>
<div class="trustburn-widget" data-trustburn-protocol="https:" data-trustburn-domain="trustburn.com" data-trustburn-widget="score" data-company-path="amypore-com" data-lang="en"></div>
More widgets

About AmyPore

AmyPore develops an innovative drug that targets a common mechanism of Alzheimer's and Parkinson's diseases.

Their lead product AmyP53 is a chimeric peptide (Alzheimer's / Parkinson's) generated through an innovative strategy of artificial intelligence applied to the molecular neuroscience. AmyP53 is capable of blocking the formation of neurotoxic structures (oligomers of amyloid proteins) responsible for these two neurodegenerative diseases (new therapeutic target, the only molecule in the world capable of acting on Alzheimer's and Parkinson's).

Their drug candidate is thus the first representative of a new therapeutic class that inhibits a fundamental mechanism common to Alzheimer's and Parkinson's diseases.